ChimeriVax-Japanese encephalitis: Phase II

In a placebo-controlled U.S. Phase II trial in 99 volunteers, injection with ChimeraVax-JE produced JEV neutralizing antibodies in 98% of subjects within 1 month. The seroconversion rate was similar f...